Compal Electronics Inc., a leading original equipment manufacturer, announced that its subsidiary Hongzhi Biomedical is actively supporting Taiwan’s new health initiative, championed by President Lai Ching-te, which emphasizes enhancing mental health support. The company’s AI brainwave stress evaluation system, already in use in psychiatric and psychosomatic clinics across major hospitals in China, is set to see an expanded range of applications.
As mental health issues gain prominence in Taiwan, Compal is leveraging AI technology to advance medical health, particularly in areas traditionally receiving less attention, such as mental health care. The AI brainwave stress assessment system generates quantitative data, aiding doctors and healthcare professionals in more effectively communicating with patients and improving disease awareness and treatment adherence.
Hongzhi Biomedical has also developed a brain degeneration risk assessment system, registered as a Class II medical device by the U.S. Food and Drug Administration. Preparations are underway for domestic inspection, with plans to develop further brainwave-assisted diagnostic applications. The company aims to integrate smart medical services through advanced software and hardware technologies, striving to elevate public brain and mental health care standards.
